Adage Capital Partners’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,474,165
| Closed | -$8.93M | – | 902 |
|
|
2024
Q3 | $8.93M | Hold |
1,474,165
| – | – | 0.02% | 630 |
|
|
2024
Q2 | $7.75M | Sell |
1,474,165
-106,210
| -7% | -$559K | 0.01% | 648 |
|
|
2024
Q1 | $13.4M | Buy |
1,580,375
+444,444
| +39% | +$3.77M | 0.03% | 544 |
|
|
2023
Q4 | $7.5M | Buy |
1,135,931
+93,400
| +9% | +$616K | 0.02% | 639 |
|
|
2023
Q3 | $3.22M | Hold |
1,042,531
| – | – | 0.01% | 709 |
|
|
2023
Q2 | $2.81M | Hold |
1,042,531
| – | – | 0.01% | 721 |
|
|
2023
Q1 | $3.1M | Hold |
1,042,531
| – | – | 0.01% | 747 |
|
|
2022
Q4 | $2.63M | Hold |
1,042,531
| – | – | 0.01% | 797 |
|
|
2022
Q3 | $1.9M | Hold |
1,042,531
| – | – | ﹤0.01% | 857 |
|
|
2022
Q2 | $3.28M | Sell |
1,042,531
-500,000
| -32% | -$1.58M | 0.01% | 846 |
|
|
2022
Q1 | $9.53M | Hold |
1,542,531
| – | – | 0.02% | 710 |
|
|
2021
Q4 | $21.9M | Hold |
1,542,531
| – | – | 0.04% | 431 |
|
|
2021
Q3 | $12.3M | Buy |
1,542,531
+192,531
| +14% | +$1.54M | 0.02% | 633 |
|
|
2021
Q2 | $38.6M | Hold |
1,350,000
| – | – | 0.08% | 272 |
|
|
2021
Q1 | $39.2M | Buy |
+1,350,000
| New | +$39.2M | 0.08% | 262 |
|